MacroGenics Sells GMP Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million
MacroGenics sells manufacturing site to Bora for $122.5M, keeps access, gains cash, and focuses on cancer drug development.
/ 2 items
MacroGenics sells manufacturing site to Bora for $122.5M, keeps access, gains cash, and focuses on cancer drug development.
FDA lifted hold on MacroGenics’ cancer study. New patients can join again; drug helps immune system fight tough ovarian cancers.